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ABSTRACT
Background: Deproteinized bovine bone mineral (DBBM) is one of the best-documented bone substitute materials for
sinus floor elevation (SFE).
Purpose: DBBM is available in two particle sizes. Large particles are believed to facilitate improved neoangiogenesis
compared with small ones. However, their impact on the rate of new bone formation, osteoconduction, and DBBM
degradation has never been reported. In addition, the implant stability quotient (ISQ) has never been correlated to
bone-to-implant contact (BIC) after SFE with simultaneous implant placement.
Materials and Methods: Bilateral SFE with simultaneous implant placement was performed in 10 Göttingen minipigs. The
two sides were randomized to receive large or small particle size DBBM. Two groups of 5 minipigs healed for 6 and 12
weeks, respectively. ISQ was recorded immediately after implant placement and at sacrifice. Qualitative histological
differences were described and bone formation, DBBM degradation, BIC and bone-to-DBBM contact (osteoconduction)
were quantified histomorphometrically.
Results: DBBM particle size had no qualitative or quantitative impact on the amount of newly formed bone, DBBM
degradation, or BIC for either of the healing periods (p > 0.05). Small-size DBBM showed higher osteoconduction after
6 weeks than large-size DBBM (p < 0.001). After 12 weeks this difference was compensated. There was no significant
correlation between BIC and ISQ.
Conclusion: Small and large particle sizes were equally predictable when DBBM was used for SFE with simultaneous
implant placement.
KEY WORDS: animal study, bone substitutes, histological analysis, implant stability, sinus floor elevation
INTRODUCTION
Ongoing pneumatization of the maxillary sinus in the
edentulous or partially edentulous posterior maxilla
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often reduces the residual subantral bone height consid-
erably. As a result, placement of implants of sufficient
length may be compromised. Placement of short
implants has been suggested as an alternative to bone
regeneration procedures in the atrophic posterior
maxilla.1 However, implants of 10 mm or more are rec-
ommended to increase the probability of long-term
implant survival.2 Therefore, maxillary sinus floor eleva-
tion (SFE) is often indicated before or simultaneously
with implant insertion in the posterior maxilla. SFE may
be performed using a lateral window or transcrestal
approach.3 With both techniques, the sinus membrane
(also referred to as the schneiderian membrane) is care-
fully elevated in a cranial direction. The created volume
is most often filled with a bone grafting material. The
most frequently encountered grafting protocols include
autogenous bone from intra- or extraoral donor sites, a
bone substitute material or combinations thereof (i.e.,
composite grafts).3
Autogenous bone grafts used alone are associated
with various degrees of resorption.4–6 In addition, the
harvesting procedure may be accompanied by signifi-
cant morbidity and complications at the donor site –
especially when autografts are harvested extraorally or
intraorally at the chin.7,8 There are thus three potential
advantages of using a bone substitute material with a
low substitution rate alone or in combination with
autogenous bone graft particles: (1) reduced volume of
autogenous bone required to achieve the treatment
objective; (2) reduced donor site morbidity; and (3)
reduced graft resorption during remodeling.6,9
One of the best-documented bone substitute mate-
rials used for SFE is a deproteinized bovine bone
mineral (DBBM) (Bio-Oss®, Geistlich Pharma, Wol-
husen, Switzerland), a porous bovine-derived bone
mineral with osteoconductive properties.10 DBBM is
available in two different particle sizes: 0.25–1 mm and
1–2 mm. It has been speculated that utilization of the
larger particles for SFE would leave more space for vas-
cular ingrowth, which is essential for bone formation in
the augmented volume.11 Therefore, large particles of
DBBM have been recommended for SFE. However, there
are no scientific data to support this recommendation.
A recent case series of 10 patients12 compared small
and large DBBM particles for SFE using a split-mouth
design and showed no difference in bone volume based
on trephine biopsies harvested after 6 to 9 months of
healing. However, no information is available on poten-
tial differences in the course of bone healing and on the
process of osseointegration of dental implants in the
augmented volume.
Pull-out strength as a measure of the stability of
dental implants after SFE was compared with bone-
to-implant contact (BIC) in experimental studies in
sheep using particulated autograft or DBBM as graft-
ing materials.13,14 However, the implant stability quo-
tient (ISQ) has gained increased popularity in recent
years as a noninvasive method to test implant stabi-
lity at implant placement, over the course of the
osseointegration period, and prior to prosthetic load-
ing.15 Experimental studies correlating ISQ and BIC
have shown divergent results.16 However, this has never
been investigated after SFE procedures with simulta-
neous placement of implants. Potentially, ISQ measure-
ments could be valuable in determining the right
time point to load an implant placed in a site where
SFE has been performed. In that respect, it would be
of great value to know the correlation between the
ISQ values and histomorphometric data of BIC, bone
density, and bone-to-DBBM contact in the entire aug-
mented volume.
The SFE model is well established in minipigs
for the comparison of the biological behavior of bone
grafting materials and bone growth factors in implant
dentistry.5,6,17–24 Implant stability has not previously
been reported using the minipig model.
The primary objective of the present study was to
study bone formation after SFE using DBBM of two
different particle sizes. The secondary aim was to corre-
late the implant stability (ISQ) of implants placed simul-
taneously with SFE to BIC and bone density around the
implants. The null hypothesis was that the particle size
of DBBM used for maxillary SFE in minipigs with
simultaneous implant placement does not influence the
following parameters: (1) amount of new bone forma-
tion; (2) rate of new bone formation; (3) bone-to-
DBBM surface contact; (4) BIC; and (5) implant
stability (ISQ values).
MATERIAL AND METHODS
The present study was approved by the veterinary
authorities supervising animal experiments, Office of
Agriculture, State Department of Canton Bern, Switzer-
land (approval no. BE39/11).
The study was performed in 10 adult Göttingen
minipigs (mean weight: 53.5 kg 1 5.3 kg [1 SD]).
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Surgical Procedure
The surgeries were performed at the Surgical Research
Unit, Department of Clinical Research and Clinic for
Large Animals, University of Bern, Switzerland. Each
animal fasted at least 12 hours before premedication
with an intramuscular injection of ketamine 20 mg/kg
body weight (Narketan®10, 100 mg/ml, Vétoquinol AG,
Bern, Switzerland) and xylazine 2 mg/kg body weight
(Xylapan® 20 mg/ml, Vétoquinol AG). General anes-
thesia was induced by an i.v. infusion of atropine
0.05 mg/kg body weight (1 mg/ml, Sintetica S.A., Men-
drisio, Switzerland) and midazolam 0.5 mg/kg body
weight (Dormicum®, Roche Pharma AG, Reinach,
Switzerland) through an ear vein. For intraoperative
protection, eye ointment (Bepanthen®, Dexpanthenol
50 mg/g, Bayer Vital, Leverkusen, Germany) was applied
in each eye. Endotracheal intubation was performed
and a controlled respiration frequency of 12 breaths/
minute was maintained with a volume of 10 ml/kg body
weight. Isoflurane 1.0–1.5% (Forene®, Abbot AG, Baar,
Switzerland) was added to a mixture of oxygen and N2O
(ratio 1:3).
Prior to surgery, the animals were given prophy-
lactic antibiotics 12,000 IU/kg body weight (benzylpeni-
cillin benzathinum 150,000 IU/ml, Duplocillin® LA,
Veterinaria AG, Zürich, Switzerland) intramuscularly.
For intraoperative pain control and hemostasis,
local anesthesia was injected in the surgical field
(4 ml articaine hydrochloride/epinephrine hydrochlo-
ride 40 mg/ml/0.006 mg/ml, Ultracaine® D-S, Sanofi-
Aventis Deutschland GmbH, Frankfurt a.M., Germany).
Through bilateral infraorbital incisions, the lateral parts
of the zygomatic bodies and arches were exposed. A
lateral window measuring 10 ¥ 10 mm was prepared
to the maxillary sinus using round burs followed by
ball-shaped diamond burs, with copious saline irriga-
tion. The schneiderian membrane was carefully elevated
using blunt dissectors. If septae were present they were
removed with a round bur to create one major sinus
compartment. An implant bed was prepared to accom-
modate an implant Ø: 4.1 mm, length: 12 mm (Strau-
mann Tissue Level Implant, Standard neck, SLActive®,
Institut Straumann AG, Basel, Switzerland) (Figure 1A).
If perforation of the schneiderian membrane occurred,
the membrane was reflected additionally and a minor
piece of collagen membrane (BioGide®, Geistlich
Pharma) was used to cover the perforation. Before
implant insertion, the posterior and superior parts of
the sinus cavity were grafted with large (1–2 mm)
or small (0.25–1 mm) particles of DBBM (Bio-Oss®,
Geistlich Pharma) according to a randomization
plan (http://www.randomization.com, seed: 16423)
A B
C D
Figure 1 Surgical photos. A, A lateral window is prepared and the schneiderian membrane elevated. In addition, the implant bed is
prepared 5 mm posterior to the lateral window. B, DBBM particles are grafted into the posterior and medial parts of the created
volume in the maxillary sinus cavity before placement of a dental implant. C, The rest of the created volume is augmented.
D, A collagen membrane is adapted to cover the lateral window.
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(Figure 1B). After implant insertion, implant stability
(ISQ) was measured using an Osstell Mentor® (Osstell
AB, Gothenburg, Sweden). Three measurements were
recorded in the horizontal direction followed by three
in the vertical direction. The rest of the created space
was grafted (Figure 1C) and the lateral window was
covered with a collagen membrane (BioGide®, Geistlich
Pharma) (Figure 1D). The soft tissues were closed in
multiple layers using resorbable sutures (Vicryl® 3-0
and 2-0, Ethicon, Norderstedt, Germany). A fentanyl
patch (Durogesic® TTS 50 mg/h, Janssen-Cilag AG, Baar,
Switzerland) was applied for postoperative pain control
and antibiotic administration was repeated twice post-
operatively, on day 3 and day 6.
The animals were checked daily for the first post-
operative week for signs of infection by the chief
veterinarian of the Surgical Research Unit.
Healing Periods
The 10 animals were divided into 2 groups of 5 animals,
which were allowed to heal for 6 weeks and 12 weeks,
respectively.
At the end of each designated healing period, the
animals were sacrificed by induction of deep anesthesia
followed by withdrawal of the entire blood volume. The
head was separated from the body and the soft tissue
and mandibles were removed. ISQ measurements were
repeated. The skull was divided at the midline using a
saw, and two blocks, each containing one entire sinus,
were harvested for histologic preparation. The pins
inserted for ISQ measurements were left in place for
later localization purposes.
Histologic Preparation
The two maxillary blocks were fixed in 10% neutral
buffered formalin combined with 1% CaCl2 for two
weeks. Each block was dehydrated and embedded in
methyl methacrylate. Using a low-speed diamond saw
with copious water cooling, all defects were sectioned in
the axis of the implant, yielding 10–15 consecutive
undecalcified sections (~600 mm in thickness). Four sec-
tions per defect (two sections containing the implant,
one section anterior, and one section posterior to the
implant) were mounted on opaque Plexiglas with acrylic
glue and ground to a final thickness of ~200 mm. Finally,
the sections were superficially stained with toluidine
blue.25
Histomorphometric Evaluation
All histomorphometric data were collected by two expe-
rienced examiners who were blinded to the treatment
modalities.
BIC was evaluated on the two most central sec-
tions of the implant as the percentage (%) of the
total implant surface covered with bone and as the
percentage of the implant surface in the augmented
sinus volume covered with newly formed bone by
counting intersections using a square grid (distance
between test lines: 0.063 mm) at a magnification of
¥160. The thickness of the lateral sinus wall (WT)
(in mm) was measured directly via the microscope
on each side of the implant on the same two sections.
The volume fractions (%) of newly formed bone (BV),
of residual DBBM filler material (DBBMV), and of soft
tissue/marrow space (ST) occupying the augmented
volume were evaluated for four sections: the two sec-
tions containing the implant and the sections 5 mm
anterior and posterior to the implant. Regions of
interest (ROI) were evaluated as illustrated in Figure 2.
The tissue fractions were determined by point count-
ing directly in the microscope, using a square grid
(distance between 6 ¥ 6 test lines: 0.1 mm) at a magni-
fication of ¥160. The percentage of graft particle
surface covered with newly formed bone (osteocon-
duction [OC]) was evaluated by counting intersections
using the same grid and magnification as mentioned
above.26
Statistical Analysis
The initial descriptive analysis of the data was done by
drawing scatter plots for the distribution of the data sets.
To detect potential differences in impact of the two
different particle sizes on the parameters tested (bone
volume, DBBM, BIC sinus, BIC total, OC, postoperative
ISQ values) for each time point, nonparametric analysis
of longitudinal data was used applying a Brunner–
Langer model.
The level of significance chosen for all statistical
tests was p 2 0.05. Due to the small sample size and the
explorative nature of this study, the p values were not
adjusted for multiple testing. Therefore, statistically
significant findings should be interpreted as trends.
The analyses of longitudinal data were performed using
a software package R (version 2.14.1; http://www.
r-project.org).
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RESULTS
Clinical Observations
One minipig had to be excluded at the time of surgery
due to an almost complete lack of maxillary sinus, bilat-
erally. Therefore an additional animal was included
to have n = 5 in each test group. Perforations of the
schneiderian membrane occurred in 13 of the 20 SFE
procedures and were observed only in cases presenting
with multiple septae. Five of 10 minipigs suffered minor
nose bleeding after the surgery, all of which stopped
spontaneously within the first 24 hours postoperatively.
All animals healed uneventfully without any clinical
signs of adverse reactions to the surgical procedure or
the applied biomaterials.
Histology
Two specimens (one with large DBBM particles at 6
weeks and one with large DBBM particles at 12 weeks)
had to be excluded from the analysis due to migration
of the DBBM particles, presumably through the perfo-
rated sinus membrane away from the ROI (Figure 2),
allowing the reformation of sinus cavities. In addition,
an infection was observed on the mesial aspect of one
implant (large DBBM particles, 6 weeks). In this speci-
men BIC was not performed, but since the infection
histologically appeared to be local and well defined, BV,
DBBMV, and OC recordings were included in the final
evaluation.
Often, the maxillary-zygomatic suture was surgi-
cally opened during removal of sinus septae on the
medial aspect of the maxillary sinus. This allowed
fibrous tissue ingrowth into the augmented volume and
around the implant, displacing the DBBM particles.
However, no histological signs of differences in graft
displacement, in healing pattern, or in maturity of newly
formed bone were observed between the two particle
sizes (small vs large DBBM particles). Therefore, the
histological description summarizes the qualitative
tissue reactions at the two time points irrespective of
DBBM particle size.
Six Weeks. Bone formation was exclusively observed
extending from the sinus walls. Maturity of the newly
formed bone, correspondingly, increased from the
periphery of the maxillary sinus. Woven bone or no
bone was observed at this time point in the center of the
augmented volume including the apex of the implants,
whereas the woven bone lattice in the periphery was
reinforced with parallel-fibered bone. Struts of woven
A B
5 mm
Figure 2 Histologic overview sections showing regions of interest for the histomorphometric evaluation. A, Overview, central section
through the dental implant. The thickness of the original sinus wall is recorded as the average between the thickness on the mesial
and on the distal aspect (green lines). In this case the sinus wall around the implant is unusually thick due to the fact that the
implant was placed in the area of a former sinus septum. The red lines delineate the area where the histomorphometric analysis of
bone volume, DBBM volume, and osteoconduction was performed on the two central sections including the dental implant. B,
Overview section 5 mm mesial to the dental implant in the area of the former lateral window. The red squares indicate the areas
where the histomorphometric evaluations were performed: a caudal-medial square, a central square, and a cranio-lateral square.
In every other section the order was shifted: a cranio-medial square, a central square, and a caudal-lateral square.
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bone reached from DBBM particle to DBBM particle,
often amalgamating the complete periphery of the
particles (Figure 3). Similarly, osseointegration of the
implants mainly took place from the sinus wall, with
woven bone extending along the implant surface
(Figure 4). DBBM particles were never observed in
direct contact with the implant surface. The soft tissue in
between the particles and the newly formed bone had
the character of a developing bone marrow, relatively
poor in cells and free of inflammation. In areas where
DBBM was engulfed by fibrous tissue originating from
the maxillary-zygomatic suture, the particles were often
completely surrounded by osteoclastic multinucleated
cells showing signs of pronounced resorptive activity
(Figure 5).
Twelve Weeks. Increased maturity and density of the
newly formed bone was observed around the DBBM
particles as well as around the implants (Figures 3 and 4).
Parallel-fibered bone dominated throughout the aug-
mented volume, and primary osteons were often seen
(Figure 3). A mature bone marrow had developed
(Figure 3). Multinucleated cells were often observed on
the surface, wherever DBBM was exposed to the bone
marrow. In contrast to the DBBM particles captured in
fibrous tissue early in the healing phase (Figure 5A), these
multinucleated cells did not show signs of active resorp-
tion and were hence localized on unaffected DBBM
surfaces or in very shallow concavities (Figure 5B).
Histomorphometry
The main findings of the histomorphometric analysis
are presented in Table 1. The total BIC and BIC within
the augmented volume both increased from week 6 to
week 12 in both test groups (p < 0.05). BV also increased
from week 6 to week 12 but without reaching statistical
significance (p > 0.05). There was a limited but signi-
ficant decrease in DBBMV from week 6 to week 12
(p < 0.001) but no difference between the two particle
sizes (p > 0.05). There was a statistically significant dif-
ference in OC of small and large particles of DBBM over
the two time periods analyzed (p < 0.001).
Implant Stability
The overall ISQ values increased significantly from 70.6
at the time of implant placement to 83.3 and 84.0 after 6
and 12 weeks, respectively (p < 0.001) (Figure 6). There
was no statistically significant correlation between initial
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Figure 3 Bone healing around small and large DBBM (*) particles after 6 and 12 weeks of healing. 6 weeks: Small (A) and large
(B) DBBM (*) particles are almost completely embedded in woven bone (WB) after 6 weeks. Limited amounts of parallel-fibered
bone (PB) are observed. The soft tissue is relatively rich in cells and free of inflammation. 12 weeks: Small (C) and large (D) DBBM
(*) particles integrated in mature parallel-fibered bone (PB) and lamellar bone (LB) with a mature bone marrow (M) in between.
A central lattice of woven bone can still be recognized (WB).
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thickness of the sinus wall in which the implant was
placed and the ISQ values at the time of implant place-
ment and at the end of each designated healing period.
Moreover, there was no statistically significant correla-
tion between ISQ and BIC at the end of the healing
periods.
DISCUSSION
The present study evaluated the influence of the particle
size of DBBM on bone formation and implant stability
when used for SFE in a well-documented minipig
model. Within the limitations of the study design, in the
initial healing phase small particle size DBBM showed
marginally higher osteoconductive capacity than large
particle size DBBM. However, no differences were
observed in amount and speed of bone formation, BIC,
or implant stability between the two test groups. The
null hypothesis could therefore be accepted.
Surgically and histologically the animal model
showed challenges that have not been reported
500 μm
6 weeks 12 weeks
A B
WB
PB
II
WB
PB
WB
BV
*
*
*
*
Figure 4 Osseointegration of implants. A, An implant with a chemically modified sandblasted acid-etched hydrophilic implant (I)
surface partly covered with a sheet of woven bone (WB) in a maxillary sinus augmented with DBBM (*) of small size after 6 weeks
of healing. Note the connection of the DBBM (*) particles with branches of woven bone and the high number of blood vessels (BV).
B, After 12 weeks of healing, bone in the peri-implant area appears considerably denser and more mature, with parallel-fibered bone
(PB) and lamellar bone dominating over woven bone (WB).
A B
OC
OC
WB
*
* *
*
100 μm
Figure 5 Degradation of DBBM. A, 6 weeks. Three DBBM (*) particles in an area with early fibrous ingrowth. One is covered with
newly formed woven bone (WB), with what appears to be an intact particle surface (arrows). The two others, however, are captured
in a cell-rich soft tissue, showing signs of pronounced resorption through multiple multinucleated osteoclast-like cells (OC).
B, 12 weeks. DBBM (*) particles are well integrated in bone and mature bone marrow. Where the DBBM surface is exposed to the
bone marrow, multiple multinucleated osteoclast-like cells (OC) are observed. However, they are situated on a flat surface or in
shallow concavities (arrows), unlike in Figure 5A.
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previously. The frequent finding of septae dividing the
maxillary sinus into multiple compartments led to a high
incidence of sinus membrane perforations and opening
of the maxillary-zygomatic suture causing ingrowth
of fibrous tissue around the implants. This anatomical
variation might be related to the different origin of
animals previously used.6,17,19–24 However, BIC values
after 6 and 12 weeks were comparable or even higher than
in previous studies using the same model.17,19,22 Due
to the very variable but most often limited size of the
TABLE 1 Results of Histomorphometric Analysis and Implant Stability Measurements
Healing Time Particle Size WT mm ISQ po ISQ sacr BIC sinus % BIC tot % BV % DBBMV % OC %
6 weeks Small
Mean 2.4 67.7 83.5 15.4 29.2 39.0 25.1 80.1
Median 2.6 66.0 84.0 15.4 28.3 39.4 26.2 79.6
SD 0.6 8.1 1.7 0.2 3.5 6.3 2.6 2.9
Large
Mean 2.7 68.2 81.8 18.7 35.1 40.0 24.6 71.0
Median 2.8 68.5 83.0 21.2 35.3 36.5 25.1 72.2
SD 0.5 7.0 3.6 4.8 3.6 7.6 1.9 5.2
12 weeks Small
Mean 3.2 73.7 83.4 35.3 53.5 44.3 21.3 83.1
Median 3.0 75.5 85.5 39.9 53.8 45.7 21.8 80.6
SD 0.7 4.9 4.3 16.3 17.9 3.2 3.6 5.0
Large
Mean 3.2 72.1 84.5 32.2 51.5 45.1 19.8 82.3
Median 2.9 74.0 85.5 32.8 49.7 46.3 20.9 82.1
SD 1.1 6.6 2.5 8.4 14.5 4.9 3.5 2.7
WT, sinus wall thickness; ISQ, implant stability quotient; po, immediately after implant placement and sinus grafting; sacr, at sacrifice; BIC, bone-to-
implant contact; BV, bone volume: fraction of newly formed bone in the augmented volume; DBBMV, DBBM volume: fraction of remaining DBBM in
the augmented volume; OC, osteoconduction: fraction of DBBM surface covered with newly formed bone.
Figure 6 Implant stability. Point plots of implant stability quotient (ISQ) values immediately after implant placement, after 6 weeks
of healing, and after 12 weeks of healing. Horizontal lines represent median values.
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sinus cavity, the same amount of DBBM (by weight)
could not be applied in all surgical sites. The residual
amount of non-grafted DBBM was weighed. However,
since the complete augmented volume was not analyzed,
these data are not reported here.
The volume of newly formed bone increased
between 6 and 12 weeks in accordance with previous
studies in the maxillary sinus of minipigs.18,24 Bone for-
mation was not influenced by the particle size of DBBM,
which is in agreement with the only human study so far
comparing small and large particle size DBBM for SFE.12
Moreover, the bone volume after 6 and 12 weeks and the
relation between the volume fractions of bone, DBBM
and soft tissue lie within the same range as previous
studies in the mandibles of minipigs,27,28 with 35–50%
bone, 25–35% DBBM, and 30–40% soft tissue, suggest-
ing a steady state to establish between the different tissue
compartments during the course of healing.
Pallesen and colleagues reported an inverse relation-
ship between particle size and volume of newly formed
bone when small and large size particulated autografts
were used in standardized calvarial defects in rabbits.29
In contrast to DBBM, autografts contain bone growth
factors.30 When particle size decreases, the surface area
increases, whereby the presentation of growth factors
may be expected to increase correspondingly. Two
rabbit studies on guided bone regeneration31 and SFE32
reported more new bone formation with small DBBM
particles than with large ones. In contrast to the present
study, the volume of graft particles in the two experi-
mental studies was significantly higher in the large par-
ticle groups, which probably allowed less volume to be
occupied by newly formed bone.
A limited but significant reduction in volume of
DBBM irrespective of particle size was observed from
week 6 to week 12. The same tendency has been reported
after SFE in humans,9 experimentally in an identical
animal model,24 and in the mandibles of minipigs.27,28
Only one study in minipigs has reported pronounced
resorption of DBBM after 6 months of healing.17 In
general, DBBM is considered to be clinically nonresorb-
able, without signs of significant degradation up to 11
years after SFE.33 However, an overall reduction of
the entire augmented volume is well known after SFE
procedures. It has mainly been studied using two-
dimensional panoramic radiographs and takes place
irrespective of the grafting protocol until it stabilizes
approximately 1 year postoperatively.34–36
The degree of volume reduction is dependent on the
resorbability of the grafting materials used. In humans,
volume reductions of 28% to 38% have been docu-
mented using autografts or b-tricalcium phosphate,
respectively.34 When DBBM was used, on the other
hand, the volume reduction was below 10%.35,36 In
minipigs, it was demonstrated three-dimensionally
using CT scans that the reduction of graft volume after
SFE was directly related to the ratio between particu-
lated autografts and DBBM.6 Degradation of DBBM was
not influenced by the size of the particles applied in
the present study. For autografts, on the other hand,
resorption has been shown to increase as the size of the
particles decreases.29 It is plausible that an almost non-
resorbable material stays nonresorbable irrespective of
the particle size, whereas resorption of degradable mate-
rials accelerates as the exposed area of the materials
increases.
An interesting finding was the pronounced resorp-
tion of DBBM in a few selected areas where fibrous
tissue from the maxillary-zygomatic suture was allowed
to grow into the augmented volume (Figure 5A). A
similar finding was reported in a recent study using a
porcine calvarial model.37 From the present study it
seems likely that DBBM particles hosted in an osseous
environment may undergo only limited resorption
whenever exposed to the marrow cavity, whereas par-
ticles captured in fibrous tissue early in the healing phase
are at significant risk of complete degradation. It may be
speculated that differences in protein adsorbed to the
DBBM alter the chemotactic effect of the biomaterial
surface and thus the type and function of the cells that
colonize the surface.38
DBBM has been shown to be highly osteoconduc-
tive in previous human39,40 and animal experimental
studies.24,27 The effect of particle size on osteoconductive
properties of DBBM has not been investigated previ-
ously. In the early healing phase, small DBBM particles
demonstrated higher osteoconductive capacity than
large particles. In addition, as particle size decreased, the
absolute surface area increased, leaving more DBBM to
be covered with bone. Therefore, based on the present
findings, a larger area of DBBM should be expected to
be “osseointegrated” when using small-sized DBBM
particles.
BIC has previously been studied after SFE using
DBBM alone with simultaneous implant placement in
humans39 and in animals.5,13,18–20 The highest BIC value
DBBM Particle Size and Sinus Floor Elevation 9
was reported in the human study (66%).39 However,
this value was achieved after 8 months of healing and is
therefore difficult to compare directly with the present
study. Five animal studies contain BIC data after 6
and/or 12 weeks of healing, as in the present study.
After 6 weeks, Liu and colleagues presented 13% BIC in
the apical part of the implants placed in minipigs.20
However, the “apical part of the implant” was not
defined, which makes comparisons to the present study
difficult. Fürst and colleagues reported 3% and 7% BIC
after 6 and 12 weeks, respectively, in minipigs.18 That
study used implants with a machined surface, which
may explain the low BIC values in the early phases of
healing. In minipigs, sheep, and dogs, moderately rough
implant surfaces demonstrated BIC values of 14%, 27%,
and 34%, respectively, after 12 weeks of healing.5,13,19
The present study documented BIC values of 15% and
19% after 6 weeks and of 35% and 32% after 12 weeks,
respectively. This compares well to the previous studies,
especially in the early healing period. However, the
present study was the first to use a chemically modified
hydrophilic sandblasted and acid-etched implant
surface, which has been shown to accelerate bone for-
mation around test implants during initial wound heal-
ing.41 Another explanation for the high amount of new
bone formation and the high BIC may be the relatively
narrow sinus anatomy observed in the present study.
The role of the anatomy has not been addressed in pre-
vious minipig studies, but from the figures it seems that
the maxillary sinus cavities might have been larger than
in the present study. Bone healing is known to take place
from the existing bone walls,24 and with reduced dis-
tance between the sinus walls, the osteogenic capacity of
the sinus may increase.42
No correlation was found between initial sinus wall
thickness and primary implant stability (ISQ). This is in
accordance with a clinical study of implant stability after
transcrestal SFE with simultaneous implant placement
in humans.43 Primary implant stability is dependent not
only on the thickness of the bone into which the implant
is placed but also on the bone density, the thread con-
figuration and shape of the implant, and the presence of
an implant neck. Therefore, all these factors should be
taken into consideration when making the clinical deci-
sion to perform a one-stage or a two-stage procedure.
To the authors’ knowledge, this is the first study to
compare ISQ with BIC values after SFE procedures. No
correlation could be observed between BIC at 6 or 12
weeks and secondary implant stability (ISQ). This is in
accordance with previous animal studies of implants
placed in nonaugmented bone.44–46 During healing,
primary stability is reduced due to remodeling of the
implant bed, while increasing osseointegration (BIC)
ensures the secondary stability of the implant.47 There-
fore, two almost identical ISQ values at implant inser-
tion and at loading represent two very different biologic
scenarios at the implant surface.48 It is therefore advis-
able to focus not only on the absolute ISQ value but also
on the longitudinal development of the ISQ value over
the course of healing. Decreasing ISQ values after the
very early healing phase (3–4 weeks), on the other hand,
might require an extended healing period until loading,
or might even be predictive of implant failure.16
CONCLUSION
Within the limitations of the present animal experimen-
tal study it is concluded that small and large particle size
DBBM perform equally predictably when used for SFE
with simultaneous implant placement.
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